Variable | ||
---|---|---|
Region of residence, n (%) | ||
East | 7297 | (51.0) |
Central | 3744 | (26.2) |
West | 3256 | (22.8) |
Hospital type, n (%) | ||
General | 4220 | (29.5) |
Specialized | 10,077 | (70.5) |
3A level hospital, n (%) | ||
Yes | 13,223 | (92.5) |
No | 1074 | (7.5) |
Gender | ||
Male | 10,092 | (70.6) |
Female | 4205 | (29.4) |
Age at diagnosis, y, mean ± SD | 58.1 ± 12.6 | |
Age at diagnosis, y | ||
< 45 | 2119 | (14.8) |
45~ 54 | 3167 | (22.2) |
55~ 64 | 4337 | (30.3) |
≥ 65 | 4674 | (32.7) |
Pathological type | ||
Adenocarcinoma | 11,270 | (78.8) |
Others | 2525 | (17.7) |
Unknown | 502 | (3.5) |
Clinical stage | ||
I | 2357 | (16.5) |
II | 2590 | (18.1) |
III | 3452 | (24.1) |
IV | 4838 | (33.8) |
Unknown | 1060 | (7.4) |
The proportion of morphological verification, % | 12,632 | (88.4) |
Number of episodes per patient, Median (P5-P95) | 1 (1–6) | |
Number of episodes per patient | ||
1 | 9667 | (67.6) |
2 | 1876 | (13.1) |
3 | 1011 | (7.1) |
4+ | 1743 | (12.2) |
Number of inpatient days per patient, Median (P25-P75) | 23 (15–38) | |
Type of therapy | ||
Surgery | 5793 | (40.5) |
Surgery & Chemotherapy | 3555 | (24.9) |
Surgery & Radiotherapy | 50 | (0.3) |
Chemotherapy | 2386 | (16.7) |
Radiotherapy | 314 | (2.2) |
Radiotherapy & Chemotherapy | 328 | (2.3) |
Palliative care | 1438 | (10.1) |
Others | 372 | (2.6) |
Unknown | 61 | (0.4) |
% of patients with any co-morbidities | 4666 | (32.6) |
% of patients with any complications | 1528 | (10.7) |